The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro.
The reported effects of nitric oxide (NO) on dopamine release from the striatum are variable and its precise effect on striatal nerve terminals is unclear. In the present study a novel method of applying NO to brain tissue in situ was employed. Photo-activation of Roussin's Black Salt (RBS), retained in isolated perfused brain tissue, was used to release NO at will upon illumination. Basal and electrically-stimulated dopamine efflux from the rat striatum in vitro was measured in real time using fast cyclic voltammetry. Illumination of an RBS pre-treated brain slice elicited a light intensity-related increase in basal dopamine efflux. Concomitantly there was a decrease in the level of electrically-stimulated dopamine efflux. Illumination in the absence of RBS pre-treatment had no effect on basal or stimulated dopamine efflux. The increase in basal dopamine efflux upon photo-activation of RBS was reduced by the presence of 10 microM oxyhaemoglobin, but was insensitive to the removal of extracellular calcium or the addition of 1 microM sulpiride. The decrease in electrically-stimulated dopamine efflux following illumination was not affected by the presence of either oxyhaemoglobin or sulpiride. It is concluded that NO, produced by photo-activation of RBS, releases dopamine from the rat striatum in vitro by a mechanism independent of extracellular calcium entry.
Black
M D
MD
Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, U.K.
Matthews
E K
EK
Humphrey
P P
PP
D000818:Animals; D002118:Calcium / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D004558:Electric Stimulation; D066298:In Vitro Techniques; D007502:Iron Chelating Agents / Q000494:pharmacology* / Q000528:radiation effects; D058085:Iron Compounds; D008027:Light; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D009569:Nitric Oxide / Q000378:metabolism*; D009573:Nitrites / Q000378:metabolism; D009603:Nitroso Compounds; D010108:Oxyhemoglobins / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013469:Sulpiride / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000528:radiation effects
D007502:Iron Chelating Agents; D058085:Iron Compounds; D009573:Nitrites; D009603:Nitroso Compounds; D010108:Oxyhemoglobins; D014665:Vasodilator Agents; D009569:Nitric Oxide; C078952:Roussin's Black Salt; D013469:Sulpiride; D002118:Calcium; D004298:Dopamine